Video-Assisted Laser Resection of Lung Metastases-Feasibility of a New Surgical Technique.

Conclusion Video-assisted laser resection of lung metastases is safe, effective, and fulfills the requirements of modern lung metastases surgery. PMID: 28110489 [PubMed - as supplied by publisher]
Source: The Thoracic and Cardiovascular Surgeon - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Thorac Cardiovasc Surg Source Type: research

Related Links:

ConclusionsThe onset of a second primary tumour was related with the primary treatment given; thus the risk for those treated with radiotherapy and androgen deprivation therapy more than doubled.ResumenIntroducción y objetivosLa aparición de segundos tumores primarios en pacientes con cáncer de próstata de alto riesgo debe tenerse en cuenta en la evolución natural de la enfermedad. Nuestro objetivo es evaluar la influencia del tratamiento primario con intención curativa de dichos pacientes en el desarrollo de segundos tumores primarios.Material y métodosEstudio retrospectivo...
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
ConclusionThe PET scan showed similar sensitivity for urological tumours to the standard imaging techniques but with higher specificity, positive predictive value and negative predictive value. This led to a change in treatment strategy for 40% of the patients in our series. The PET scan will probably become the standard test in the extension and follow-up studies of most urological tumours.ResumenIntroducciónEn los últimos años han surgido nuevos estudios de imagen en diagnóstico y seguimiento de tumores urológicos metastásicos.Material y métodosSe revisa a 41 pacientes con...
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
Publication date: Available online 13 December 2018Source: Actas Urológicas Españolas (English Edition)Author(s): J.M. Cózar, B. Miñana, F. Gómez-Veiga, A. Rodríguez-Antolín, GESCAP GroupAbstractAimsTo describe the 3-year progression-free survival (PFS), overall survival (OS) and disease-specific mortality in the prospective prostate cancer GESCAP cohort, as well as the progression to castration resistance in patients on hormone therapy.Material and methodsProspective, observational, epidemiological, multicentre study. Of the 4087 patients recruited, 3843 were evaluable. The...
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
ConclusionsThe diagnostic performance of CB in patients with at least one previous negative biopsy was 44%, increasing according to the PI-RADS grade, and low in PI-RADS 3. No clinical variable predictive of cancer was found in patients with PI-RADS 3.ResumenIntroducciónEvaluación de la efectividad de la biopsia cognitiva (BC) en los pacientes con sospecha clínica de cáncer de próstata (caP) y al menos una biopsia negativa (BTR).Material y métodoAnálisis retrospectivo de 144 pacientes con al menos una BTR y una resonancia magnética nuclear (RMN) previa. Los nód...
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
ConclusionsPatient portals may offer an opportunity to build sustainable programs for decision support and assistance that are integrated with clinic workflows and processes.
Source: American Journal of Preventive Medicine - Category: International Medicine & Public Health Source Type: research
Conclusion: Hepatectomy for HCC in elderly patients is justified.Eur Surg Res 2018;59:380 –390
Source: European Surgical Research - Category: Surgery Source Type: research
Claire Daly, 34, of  Coventry, West Midlands, was just days into the three-week break with her husband Matt, 43, in September 2015 when she became fatigued and under the weather.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
This Guest Editorial introduces this month's special Pancreatic Cancer Theme Issue, a series of reviews intended to highlight the pathologic to molecular profiles and diagnoses of benign and neoplastic pancreatic lesions.
Source: American Journal of Pathology - Category: Pathology Authors: Tags: Guest editorial Source Type: research
Pancreatic ductal adenocarcinoma (PDAC) remains a challenging disease that is mostly diagnosed late in the course of the illness. Unlike other cancers in which measurable successes have been achieved with traditional chemotherapy, targeted therapy, and, recently, immunotherapy, PDAC has proved to be poorly responsive to these treatments, with only marginal to modest incremental benefits using conventional cytotoxic therapy. There is, therefore, a great unmet need to develop better therapies based on improved understanding of biology and identification of predictive and prognostic biomarkers that would guide therapy.
Source: American Journal of Pathology - Category: Pathology Authors: Tags: Review Source Type: research
Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate of only 8% and is estimated to be the second leading cause of cancer-related deaths by 2021. Prior convention held that screening for PDAC would not be beneficial; however, a deeper understanding of the carcinogenesis pathway supports a potential window of opportunity among the target population. Screening for PDAC is not a standard practice among the general population because of its low incidence. However, screening may be beneficial for individuals with familial history, chronic diseases with genetic predispositions, or inherited cancer syndromes, such a...
Source: American Journal of Pathology - Category: Pathology Authors: Tags: Review Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Colorectal Cancer | Heart | Kidney Cancer | Laser Surgery | Melanoma | Oropharyngeal Cancer | Renal Cell Carcinoma | Seminoma | Skin Cancer | Study | Testicular Cancer | Women